Jacques P. Tremblay
Quebec, QC G1V0A6, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 116 publications
Prime Editing Mediated Generation and Correction of the mdx5cv Mutation Restores Dystrophin Expression in Myoblasts.
Journal: International journal of molecular sciences
Published: July 01, 2026
Successful In Vitro Modification of the Dmd Gene Using Prime Editing.
Journal: Cells
Published: February 11, 2026
RAPID: evaluation of Cas12a protospacer nicking and chimeric reporters for PAM-independent RNA and DNA diagnostics.
Journal: Nucleic acids research
Published: October 15, 2025
Correction: Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, Canada.
Journal: Frontiers in medicine
Published: September 22, 2025
In Vitro Correction of Point Mutations in the DYSF Gene Using Prime Editing.
Journal: International journal of molecular sciences
Published: April 28, 2025
Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, Canada.
Journal: Frontiers in medicine
Published: March 05, 2025
Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1 Channel.
Journal: International journal of molecular sciences
Published: February 24, 2025
Molecular characterization of a new R1925X point mutation mouse model for dysferlinopathy.
Journal: Genes & diseases
Published: December 02, 2024
Correcting pathogenic mutations using prime editing: an overview
Journal: Medecine sciences : M/S
Published: October 25, 2024
Human MuStem cells are competent to fuse with nonhuman primate myofibers in a clinically relevant transplantation context: A proof-of-concept study.
Journal: Journal of neuropathology and experimental neurology
Published: May 16, 2024
Emerging Perspectives on Prime Editor Delivery to the Brain.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 09, 2024
Last Updated: 09/26/2026